SS
Sanjeev Singal
About Sanjeev Singal
Data last updated:
Sanjeev Singal is a Managing Director at Preet Remedies Limited (since 2005), Managing Director at Zenlabs Ethica Limited (since 2008) and Director at Quixotic Pharma Private Limited (since 2002), and holds 4 more current directorships. The companies operate in Pharma and Financial Services. The 6 current companies with reported revenue have a combined latest revenue of ₹159 Cr; the largest is Preet Remedies Limited at ₹62.83 Cr (FY 2025). Earlier, Sanjeev Singal was a Director at Zen Labs India Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Preet Remedies Limited U24230CH2005PLC027954 | Managing Director | 15 Mar 2005 | 2005 | ₹62.83 Cr (FY 2025) | Active |
 Zenlabs Ethica Limited L74900CH1993PLC033112 | Managing Director | 27 Aug 2008 | 1993 | ₹51.47 Cr (FY 2025) | Active |
 Quixotic Pharma Private Limited U24232PB2002PTC025609 | Director | 29 Nov 2002 | 2002 | ₹27.58 Cr (FY 2025) | Active |
 Oasis Pharma And Phytomolecules Private Limited U24100CH2007PTC045485 | Director | 12 Dec 2014 | 2007 | ₹10.36 Cr (FY 2025) | Active |
 Ultra Chiron Pharmaceuticals Pvt Ltd U24231CH1993PTC013535 | Managing Director | 20 Jul 1993 | 1993 | ₹6.09 Cr (FY 2025) | Active |
| Ultra Chiron Healthcare Private Limited U24230PB2004PTC027270 | Director | 02 Jul 2004 | 2004 | ₹44.2 Lakh (FY 2025) | Active |
| Quadriga Biotech Private Limited U24232CH2007PTC030684 | Director | 31 Jan 2007 | 2007 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Zen Labs India Private Limited U24232CH2009PTC031494 | Director | 27 Jan 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjeev Singal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjeev Singal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjeev Singal
Sanjeev Singal currently holds 7 directorships: Preet Remedies Limited (Managing Director, since 15 Mar 2005, revenue ₹62.83 Cr (FY 2025)); Zenlabs Ethica Limited (Managing Director, since 27 Aug 2008, revenue ₹51.47 Cr (FY 2025)); Quixotic Pharma Private Limited (Director, since 29 Nov 2002, revenue ₹27.58 Cr (FY 2025)); Oasis Pharma And Phytomolecules Private Limited (Director, since 12 Dec 2014, revenue ₹10.36 Cr (FY 2025)); Ultra Chiron Pharmaceuticals Pvt Ltd (Managing Director, since 20 Jul 1993, revenue ₹6.09 Cr (FY 2025)); and 2 more.
Sanjeev Singal was first appointed on 20 Jul 1993 as Managing Director at Ultra Chiron Pharmaceuticals Pvt Ltd. The most recent appointment on record is 12 Dec 2014 at Oasis Pharma And Phytomolecules Private Limited.
The 6 current companies of Sanjeev Singal that report revenue have a combined latest revenue of ₹159 Cr: Preet Remedies Limited ₹62.83 Cr (FY 2025); Zenlabs Ethica Limited ₹51.47 Cr (FY 2025); Quixotic Pharma Private Limited ₹27.58 Cr (FY 2025); Oasis Pharma And Phytomolecules Private Limited ₹10.36 Cr (FY 2025); Ultra Chiron Pharmaceuticals Pvt Ltd ₹6.09 Cr (FY 2025); and 1 more.
Sanjeev Singal held 1 earlier board appointment: Zen Labs India Private Limited (Director, from 27 Jan 2009).
The current boards of Sanjeev Singal's companies include Abhishek Rana (Preet Remedies Limited), Hitesh Popatlal Oswal (Preet Remedies Limited), Prasanna Kumar Rout (Preet Remedies Limited), Sanjay Dhir (Preet Remedies Limited), Vijendra Kumar Gupta (Preet Remedies Limited), Anurag Malhotra (Zenlabs Ethica Limited), among others.